Apr. 29 at 8:40 PM
$CNMD Q1 '26 Earnings Results & Recap
• Reported GAAP EPS of
$0.45 up 136.84% YoY
• Reported revenue of
$317.05M down -1.31% YoY
• Conmed is raising its full-year 2026 organic constant currency revenue growth outlook to 5.0% to 6.5% and expects reported revenue of
$1.350 billion to
$1.375 billion. Conmed reaffirms full-year adjusted diluted net earnings per share in the range of
$4.30 to
$4.45.
